Abstract
Hypnosedatives are used extensively in older people, although their usage has fallen since the early 1970s. Increasing consumer concerns now risk underuse of these drugs, even in appropriate situations. High quality prescribing of hypnosedatives requires consideration of the pharmacokinetics and pharmacodynamics of these drugs, an understanding of their adverse effects, efficacy and clinical situations in which they may be of use, and an appreciation of the role of non-pharmacological therapy. If these issues are adequately addressed, hypnosedatives can be used effectively to treat insomnia and some anxiety disorders. Hypnosedative prescribing can be improved through regular audits, and the development of a local prescribing policy and educational programmes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
